Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul;10(6):525-527.
doi: 10.1002/ueg2.12260. Epub 2022 Jun 15.

Artificial intelligence in Barrett's oesophagus and the need for shared and combined data

Affiliations
Editorial

Artificial intelligence in Barrett's oesophagus and the need for shared and combined data

Rüdiger Schmitz et al. United European Gastroenterol J. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Jakob N. Kather declares consulting services for Owkin, France, and Panakeia, UK. Rüdiger Schmitz has no conflict of interest to disclose.

Comment on

Similar articles

References

    1. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high‐grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology. 1993;105(1):40–50. 10.1016/0016-5085(93)90008-Z - DOI - PubMed
    1. Klaver E, Bureo Gonzalez A, Mostafavi N, Mallant‐Hent R, Duits LC, Baak B, et al. Barrett’s esophagus surveillance in a prospective Dutch multi‐center community‐based cohort of 985 patients demonstrates low risk of neoplastic progression. United Eur Gastroenterol J. 2021;9(8):929–37. 10.1002/ueg2.12114 - DOI - PMC - PubMed
    1. Abrams JA, Kapel RC, Lindberg GM, Saboorian MH, Genta RM, Neugut AI, et al. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol. 2009;7(7):736–42. 10.1016/j.cgh.2008.12.027 - DOI - PMC - PubMed
    1. Duits LC, Phoa KN, Curvers WL, ten Kate FJW, Meijer GA, Seldenrijk CA, et al. Barrett’s oesophagus patients with low‐grade dysplasia can Be accurately risk‐stratified after histological review by an expert pathology panel. Gut. 2015;64(5):700–6. 10.1136/gutjnl-2014-307278 - DOI - PubMed
    1. Parasa S, Vennalaganti S, Gaddam S, Vennalaganti P, Young P, Gupta N, et al. Development and validation of a model to determine risk of progression of Barrett’s esophagus to neoplasia. Gastroenterology. 2018;154(5):1282–9. e2. 10.1053/j.gastro.2017.12.009 - DOI - PubMed